Single-ventricular Extracorporeal Life Support Devices Market contains market size and forecasts of Single-ventricular Extracorporeal Life Support Devices in global, including the following market information:
- Global Single-ventricular Extracorporeal Life Support Devices Market Revenue, 2018-2023, 2023-2030, ($ millions)
- Global Single-ventricular Extracorporeal Life Support Devices Market Sales, 2018-2023, 2023-2030, (Units)
Global top five Single-ventricular Extracorporeal Life Support Devices companies in 2022 (%)
The global Single-ventricular Extracorporeal Life Support Devices market was valued at million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period 2023-2030.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million by 2030.
VA Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Single-ventricular Extracorporeal Life Support Devices include LivaNova, MAQUET Holding, Medtronic, Microport Scientific, Sorin Group, Nipro Medical, Terumo Cardiovascular Systems and MedosMedizintechnik, etc. In 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Single-ventricular Extracorporeal Life Support Devices manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Single-ventricular Extracorporeal Life Support Devices Market, by Type, 2018-2023, 2023-2030 ($ Millions) & (Units)
Global Single-ventricular Extracorporeal Life Support Devices Market Segment Percentages, by Type, 2022 (%)
Global Single-ventricular Extracorporeal Life Support Devices Market, by Application, 2018-2023, 2023-2030 ($ Millions) & (Units)
Global Single-ventricular Extracorporeal Life Support Devices Market Segment Percentages, by Application, 2022 (%)
- Hospital
- Specialty Clinic
- Other
Global Single-ventricular Extracorporeal Life Support Devices Market, By Region and Country, 2018-2023, 2023-2030 ($ Millions) & (Units)
Global Single-ventricular Extracorporeal Life Support Devices Market Segment Percentages, By Region and Country, 2022 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Single-ventricular Extracorporeal Life Support Devices revenues in global market, 2018-2023 (Estimated), ($ millions)
- Key companies Single-ventricular Extracorporeal Life Support Devices revenues share in global market, 2022 (%)
- Key companies Single-ventricular Extracorporeal Life Support Devices sales in global market, 2018-2023 (Estimated), (Units)
- Key companies Single-ventricular Extracorporeal Life Support Devices sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
- LivaNova
- MAQUET Holding
- Medtronic
- Microport Scientific
- Sorin Group
- Nipro Medical
- Terumo Cardiovascular Systems
- MedosMedizintechnik
Industry Market Size
